HaltTM Phosphatase Inhibitor Cocktail

SECTION 2: Hazards identification

Directive 1999/45/EC: Physical state : Liquid. [Clear sparkling liquid.] Odor : Odorless.

Principle Routes of Exposure

Eye contact. Inhalation. Ingestion.

Potential Acute Health Effects

Inhalation : Irritating to respiratory system. Ingestion : Toxic if swallowed. Skin : Harmful in contact with skin. Irritating to skin. Eyes : Irritating to eyes. Potential chronic health effects

Potential chronic health

Contains material that can cause target organ damage. Carcinogenicity : Contains material which may cause cancer. Risk of cancer depends on duration and level of exposure. Mutagenicity : No known significant effects or critical hazards.

Teratogenic Effects

No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which causes damage to the following organs: heart, bones, teeth. Contains material which may cause damage to the following organs: kidneys, gastrointestinal tract, upper respiratory tract, skin, central nervous system (CNS), eye, lens or cornea. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions aggravated by over- exposure : Pre-existing skin and digestive disorders and disorders involving any other target organs mentioned in this MSDS as being at risk may be aggravated by over-exposure to this product. The preparation is not classified as dangerous according to Directive 1999/45/EC and its amendments.

2.1 Classification of the substance or mixture

Not classified. See toxicological information (section 11)